(Q40620465)

22 September 2017

6 references

3 April 2019

8 September 2019

28 November 2019

15 December 2019

2 November 2020

4 November 2020

The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia (English)

1 reference

regulation of gene expression

22 September 2017

acute myeloid leukemia

6 references

3 April 2019

8 September 2019

28 November 2019

15 December 2019

2 November 2020

4 November 2020

1 reference

8 September 2019

1 reference

28 November 2019

1 reference

15 December 2019

1 reference

1 reference

2 November 2020

neoplastic gene expression regulation

1 reference

4 November 2020

Holmes JA

1

1 reference

22 September 2017

West RR

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 February 1994

7 references

British Journal of Cancer

22 September 2017

3 April 2019

8 September 2019

28 November 2019

15 December 2019

2 November 2020

4 November 2020

7 references

22 September 2017

3 April 2019

8 September 2019

28 November 2019

15 December 2019

2 November 2020

4 November 2020

69

1 reference

22 September 2017

2

1 reference

22 September 2017

382-384

1 reference

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Mechanism of multidrug resistance

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Multidrug resistance (mdr) genes in human cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Effect of position 185 mutations of the MDR-1 gene on drug resistance in leukaemia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968682

Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7905280

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Why do we need systematic overviews of randomized trials?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7905280

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1994.70

1 reference

22 September 2017

1 reference

22 September 2017

PubMed publication ID

7905280

1 reference